CD40 is functionally expressed on human breast carcinomas: Variable inducibility by cytokines and enhancement of Fas-mediated apoptosis

被引:66
作者
Wingett, DG
Vestal, RE
Forcier, K
Hadjokas, N
Nielson, CP
机构
[1] VA Med Ctr, Res Serv 151, Boise, ID 83702 USA
[2] Univ Washington, Dept Med, Seattle, WA USA
关键词
apoptosis; breast-neoplasms; carcinoma; CD40; Fas; IFN-gamma;
D O I
10.1023/A:1006012607452
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The CD40 molecule, a member of the TNF receptor gene family, has been intensively studied with respect to regulation of B cell proliferation and survival. Although CD40 is also expressed on carcinoma cell lines, information concerning the biological function of CD40 on cells of epithelial origin is limited. In this study we detected constitutive CD40 on human breast carcinoma cell lines and an increase in CD40 expression following treatment with cytokines IL-1 alpha and IFN-gamma. CD40 ligation was also found to increase MHC II expression in cells pretreated with IFN-gamma. In contrast to normal B cells, where CD40 signaling provides a potent survival signal, we observed that CD40 ligation in breast carcinoma cells results in growth inhibition and enhanced susceptibility to Fas-mediated apoptosis. Enhanced apoptosis appears to be attributable, at least in part, to an up-regulation of Fas expression caused by CD40 ligation. These results suggest a potentially important role for CD40 in breast tumor biology.
引用
收藏
页码:27 / 36
页数:10
相关论文
共 42 条
[1]   CD40 EXPRESSION BY HUMAN MONOCYTES - REGULATION BY CYTOKINES AND ACTIVATION OF MONOCYTES BY THE LIGAND FOR CD40 [J].
ALDERSON, MR ;
ARMITAGE, RJ ;
TOUGH, TW ;
STROCKBINE, L ;
FANSLOW, WC ;
SPRIGGS, MK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (02) :669-674
[2]  
Baker SJ, 1996, ONCOGENE, V12, P1
[3]   LONG-TERM HUMAN B-CELL LINES DEPENDENT ON INTERLEUKIN-4 AND ANTIBODY TO CD40 [J].
BANCHEREAU, J ;
DEPAOLI, P ;
VALLE, A ;
GARCIA, E ;
ROUSSET, F .
SCIENCE, 1991, 251 (4989) :70-72
[4]   MHC CLASS-II TRANSFECTED TUMOR-CELLS INDUCE LONG-TERM TUMOR-SPECIFIC IMMUNITY IN AUTOLOGOUS MICE [J].
BASKAR, S ;
AZARENKO, V ;
MARSHALL, EG ;
HUGHES, E ;
OSTRANDROSENBERG, S .
CELLULAR IMMUNOLOGY, 1994, 155 (01) :123-133
[5]   LOSS OF HLA CLASS-I EXPRESSION IN PROSTATE-CANCER - IMPLICATIONS FOR IMMUNOTHERAPY [J].
BLADES, RA ;
KEATING, PJ ;
MCWILLIAM, LJ ;
GEORGE, NJR ;
STERN, PL .
UROLOGY, 1995, 46 (05) :681-686
[6]   REGULATION OF IMMUNOGLOBULIN PRODUCTION BY NERVE GROWTH-FACTOR - COMPARISON WITH ANTI-CD40 [J].
BRODIE, C ;
GELFAND, EW .
JOURNAL OF NEUROIMMUNOLOGY, 1994, 52 (01) :87-96
[7]   CONTENDERS IN FASL/TNF DEATH SIGNALING [J].
CLEVELAND, JL ;
IHLE, JN .
CELL, 1995, 81 (04) :479-482
[8]   DIFFERENCES IN MHC AND TAP-1 EXPRESSION IN CERVICAL-CANCER LYMPH-NODE METASTASES AS COMPARED WITH THE PRIMARY TUMORS [J].
CROMME, FV ;
VANBOMMEL, PFJ ;
WALBOOMERS, JMM ;
GALLEE, MPW ;
STERN, PL ;
KENEMANS, P ;
HELMERHORST, TJM ;
STUKART, MJ ;
MEIJER, CJLM .
BRITISH JOURNAL OF CANCER, 1994, 69 (06) :1176-1181
[9]  
Eliopoulos AG, 1996, ONCOGENE, V13, P2243
[10]   CD40 EXPRESSION BY HUMAN FIBROBLASTS [J].
FRIES, KM ;
SEMPOWSKI, GD ;
GASPARI, AA ;
BLIEDEN, T ;
LOONEY, RJ ;
PHIPPS, RP .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1995, 77 (01) :42-51